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Abstract
Precise regulation of free intracellular Ca2+ concentrations [Ca2+]i is critical for normal neuronal
function, and alterations in Ca2+ homeostasis are associated with brain aging and
neurodegenerative diseases. One of the most important proteins controlling [Ca2+]i is the plasma
membrane Ca2+-ATPase (PMCA), the high affinity transporter that fine tunes the cytosolic
nanomolar levels of Ca2+. We previously found that PMCA protein in synaptic plasma membranes
(SPMs) is decreased with advancing age and the decrease in enzyme activity is much greater than
that in protein levels. In the present study, we isolated raft and non-raft fractions from rat brain
SPMs and used quantitative mass spectrometry to show that the specialized lipid microdomains in
SPMs, the rafts, contain 60% of total PMCA, comprised of all four isoforms. The raft PMCA pool
had the highest specific activity and this decreased progressively with age. The reduction in
PMCA protein could not account for the dramatic activity loss. Addition of excess CaM to the
assay did not restore PMCA activity to that in young brains. Analysis of the major raft lipids
revealed a slight age-related increase in cholesterol levels and such increases might enhance
membrane lipid order and prevent further loss of PMCA activity.
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Introduction
Transient increases in free intracellular Ca2+ serve as signals in critical neuronal processes
such as neurotransmitter release, energy metabolism, synaptic plasticity, and gene
transcription essential for learning and memory (Berridge 1998; Blackstone and Sheng
2002). The cytosolic Ca2+ must be rapidly returned to normal resting levels following Ca2+
transients and maintained in the nanomolar concentration range through the activities of
Ca2+ transporters and binding proteins. Aberrant cellular Ca2+ overload has been implicated
in neuronal dysfunction occurring in brain aging (Huidobro et al. 1993; Khachaturian 1994;
Camandola and Mattson 2011) and in neurodegenerative disorders such as Alzheimer’s
disease (Khachaturian 1994; Mattson 2007; Camandola and Mattson 2011), and Parkinson’s
disease and stroke (Mattson 2007). The aging process in brain is accompanied by a higher
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overall Ca2+ content in brain neurons and synaptic terminals and a slower clearance of Ca2+
from nerve endings following a depolarizing stimulus (Martinez et al. 1988; Michaelis et al.
1992).
The calmodulin (CaM)-activated plasma membrane Ca2+-ATPase (EC 3.6.3.8) or PMCA is
the major high-affinity, low-capacity Ca2+ extrusion system at the plasma membrane. Four
isoforms of PMCA have been identified and form a multi-gene family with numerous splice
variants that are selectively expressed in various tissues and presumably control diverse and
highly regulated functions within a given type of cell (Strehler and Zacharias 2001). By
pumping excess cytosolic Ca2+ into the extracellular space, PMCA is partly responsible for
the long term regulation of resting free intracellular Ca2+ concentrations and reversing
transient increases that occur during Ca2+ signaling (Strehler and Zacharias 2001; Clapham
2007). The PMCA levels and ATPase activity in brain synaptic membranes have been found
to decrease with brain aging, an observation that could, at least partially, explain the age-
associated elevations in intra-neuronal free Ca2+ (Gibson and Peterson 1987; Martinez et al.
1988; Michaelis et al. 1992) and the slower decay of Ca2+ transients in intact synaptosomes
(Martinez-Serrano et al. 1992) and in hippocampal neurons (Landfield and Pitler 1984) from
aged F344 rats. We had previously observed that both Ca2+-ATPase and the ATP-dependent
Ca2+ transport activity in synaptic plasma membranes (SPMs) prepared from brains of aged
Fisher 344 rats was significantly lower than that in young animals (Michaelis et al. 1984;
Michaelis 1989). We further confirmed the progressive age-dependent decrease in PMCA
activity in the longer-lived Fisher 344/BNF1 hybrid rat strain. The Vmax for activity in
SPMs isolated from 34 month old rats was 48% lower than that at 5 mos, and this decrease
was only partially due to a reduction in PMCA protein levels in the SPMs (Zaidi et al.
1998). In addition to the 20% reduction in PMCA levels, the amount of CaM present in the
membranes was reduced by approximately 30%. However, the addition of saturating
amounts of exogenous CaM did not overcome the progressive decrease in the PMCA
activity measured in SPMs from the aged rats.
Several lipids are known to regulate PMCA activity, and the activating effect of acidic
phospholipids is even more pronounced than that of CaM (Di Leva et al. 2008). The activity
of PMCA is quite sensitive to the biophysical properties of the surrounding lipid
environment, and the transporter exhibits much higher activity when it is localized in
regions of ordered lipids (Duan et al. 2006; Tang et al. 2006). A portion of the PMCA in
SPMs partitions into lipid ‘rafts’ (Sepulveda et al. 2006; Jiang et al. 2007), highly ordered
micro-domains within the plasma membrane that are enriched in cholesterol, saturated
phospholipids, and sphingolipids such as GM1 ganglioside (Brown and London 1997;
Lucero and Robbins 2004). The rafts are involved in signal transduction by acting as a
scaffold for protein sorting and promoting protein-lipid and protein-protein interactions
(Simons and Toomre 2000) as exemplified in synaptic membranes (Hering et al. 2003; Gil et
al. 2006). Cholesterol plays a key role in supporting the tendency of saturated phospholipids
and sphingolipids to segregate from unsaturated phospholipids in the bilayer membrane
(Silvius 2003), suggesting that altered cholesterol levels likely influence the activity of
proteins such as PMCA within the raft domains.
The aims of the present study were: (1) to assess the partitioning of PMCA isoforms into raft
and non-raft domains isolated from brain SPMs, (2) to determine the specific activity of the
PMCA associated with the raft vs that present in the non-raft domains, (3) to assess the
effects of aging on the specific activity of the PMCA within the raft domains of the SPMs,
and (4) to assess the levels of CaM, cholesterol and ganglioside GM1 in the rafts with
increasing age as possible contributors to the age-dependent decrease in PMCA activity seen
in intact SPMs. In the present study, we used quantitative liquid chromatography-mass
spectrometry (LC-MS/MS) to assess the relative enrichment of PMCA isoforms in raft
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domains isolated from synaptic membranes. We also examined the constants (Vmax and
Kact) for the activity of PMCA in raft and non-raft domains and determined the presence and
activity of CaM remaining tightly bound to the lipid rafts. Following such characterization
of the lipid rafts and of the PMCA associated with these lipid microdomains, we focused on
the effects of increasing age on cholesterol, GM1, PMCA, and CaM content in rafts, and on
the activity of PMCA associated with rafts.
Materials and Methods
Materials
Sources for the various primary antibodies were as follows: anti-Flotillin-1 (FLT-1) and
anti-Thy-1 (BD Biosciences), anti-CaM (Millipore), pan anti-PMCA (Affinity Bioreagents).
Alkaline phosphatase-conjugated secondary antibodies, ficoll, ouabain, thapsigargin,
oligomycin, ATP, Brij 98, and horseradish peroxidase-coupled cholera toxin subunit B
(CTXB) were purchased from Sigma. The Amplex Red cholesterol assay kit and gradient
gels (8–16%) were obtained from Invitrogen, the bicinchoninic acid protein assay reagents
from Pierce Biotechnology, and the polyvinylidene fluoride (PVDF) membranes from
Millipore. The protease inhibitor cocktail III and purified bovine brain CaM were purchased
from Calbiochem.
Animals
Fisher 344/Brown Norway hybrid (F344/BNF1) male rats at 6, 23, and 34 months of age
were obtained from the National Institute on Aging colony maintained by Harlan Industries.
All protocols were implemented in accordance with NIH guidelines and approval by the
University of Kansas Institutional Animal Care and Use Committee (IACUC). The rats were
quarantined for 2 weeks after their arrival, following which they were used for the studies.
Isolation of SPMs and SPM rafts from rat brains
Fisher 344/BNF1 rats were anesthetized by CO2 inhalation according to the IACUC
guidelines. Rats were decapitated using a guillotine and the brains recovered quickly. The
brains from one rat at each of the 3 ages were processed in parallel. Argon was bubbled
through all solutions to eliminate O2. Each whole brain was homogenized and processed
immediately for the isolation of synaptosomes by discontinuous ficoll density gradient
centrifugation as previously described (Michaelis et al. 1983; Jiang et al. 2010). The
synaptosomes recovered from the gradient were lysed in a hypotonic buffer (3mM Tris-HCl,
pH 8.5) containing a cocktail of protease inhibitors and centrifuged at 64,200 × g for 15 min.
The SPM pellet was homogenized in buffer containing 10 mM Tris-HCl, 50 μM MgCl2, and
0.32 M sucrose, pH 7.4. Lipid rafts were isolated from SPMs using discontinuous sucrose
density gradient centrifugation essentially as described (Jiang et al. 2007). Briefly, the SPMs
from each animal were solubilized in an equal volume of solubilization buffer (50 mM Tris-
HCl, 150 mM NaCl, pH 7.5, containing 2% Brij 98), to achieve 1% Brij 98 as the final
concentration, and incubated on ice for 30 min. The suspension was mixed 1:1 with a 90%
sucrose solution and the resultant mixture overlaid with 35% and 5% sucrose solutions.
Ultracentrifugation was performed for 18 h at 98,300 × g in a Beckman Optima Max
centrifuge in an MLS-50 rotor. Ten fractions (0.4 ml each) were collected from the top to
the bottom of each tube. However, due to the negligible amount of protein in fraction 1 and
the small pellet of fraction 10 at the bottom of the tube, only fractions 2 – 9 were used in
these experiments. Protein concentrations of the fractions were determined using the
bicinchoninic acid assay according to the manufacturer’s instructions. In order to compare
the raft fractions with the non-raft domains, we pooled the fractions into 3 groups. Based on
the relative levels of cholesterol, GM1, and Flotillin-1, fractions #2 – 4 were pooled as the
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lipid raft microdomains. Fractions #5–6 and #7–9 were considered to be the higher density
non-raft components of the SPMs.
Cholesterol and GM1 analysis
Cholesterol was measured using the Amplex Red cholesterol assay kit, and GM1
ganglioside levels were determined by immunoblotting using cholera toxin subunit B
(CTXB) at 300 μg/ml. Briefly, an 8 μg protein aliquot from each fraction was separated by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), transferred to a
PVDF membrane, blocked with 1% bovine serum albumin (BSA) for 30 min, and exposed
to CTXB for 2 h. Color was developed by incubation in a mixture of 1.4 mM 3,3′-
diaminobenzidine tetrahydrochloride, 200 mM NiCl and 6.2 mM H2O2. Based on the levels
of cholesterol and GM1 ganglioside associated with the various fractions, the contents of
specific fractions were pooled into 3 groups: fraction #2–4, #5–6, and #7–9. These 3 groups
were analyzed.
Immunoblot Analysis
Proteins were separated by SDS-PAGE and transferred to PVDF membranes as we have
described previously (Jiang et al. 2007). Non-specific interactions were blocked with 5% (w/
v) milk solution for 1 h at 25°C and the membranes incubated overnight with the indicated
concentrations of primary antibodies. Alkaline phosphatase-conjugated secondary antibodies
(1:1000) were added for 2 h at 25°C. Immunoblots were developed using the substrate 5-
bromo-4-chloro-3-indoyl phosphate and nitroblue tetrazolium. Blots were scanned using a
Kodak Image Station 4000MM PRO and quantified using Carestream Molecular Imaging
Software 5.x.
Capillary liquid chromatography- mass spectrometry (LC-MS/MS) analysis of PMCA
isoforms
Protein samples from pooled fractions # 2–4, #5–6, and #7–9 were run on SDS-PAGE gels
and stained with Coommassie blue. Gel pieces at the molecular weight range of PMCA were
excised, the proteins within the slices reduced with dithiothreitol, alkylated with
iodoacetamide, and digested (37 °C, overnight) with 0.25 μg of trypsin in 0.2 M NH4CO3 -
5% acetonitrile (ACN). Ten microliter peptide-containing samples were analyzed by LC-
MS/MS using a NanoAcquity chromatographic system (Waters Corp.) coupled to an LTQ-
FT mass spectrometer (ThermoFinnigan). The peptides were separated on a C18 column
(5cm, 300 μm I.D.; Thermo Acclaim PepMap300; flow rate 10 μL/min) using a gradient 1 –
40% of solvent B (99.9% ACN, 0.1% formic acid) developed over 50 min, ramped to 95%
solvent B over 4 min, and held at 95% for 5 min. Solvent A was 99.9% H2O, 0.1% formic
acid. A NanoAquity UPLC Console (Waters Corp., version 1.3) was used to execute the
injections and gradients. The ESI source was operated with spray voltage of 2.8 kV, a tube
lens offset of 160 V, and a capillary temperature of 200 °C. All other source parameters
were optimized for maximum sensitivity of the YGGFL peptide MH+ ion at m/z 556.27.
The instrument was calibrated using an automatic routine based on a standard calibration
solution. Data acquisition via LTQ-FT was set up using Xcalibur software (ThermoElectron
Corp., version 2.0.7). Full MS survey scans were acquired at a resolution of 50,000 with an
Automatic Gain Control (AGC) target of 5×105. The LTQ-FT Selected Ion Monitoring
(SIM) scan sequence was adapted from that described (Olsen and Mann 2004).
MS/MS spectra were analyzed using Mascot (Matrix Science, 2.3), Sequest (Thermo Fisher
Scientific, 27, rev. 12), and X! Tandem (The GPM, thegpm.org; CYCLONE
(2010.12.01.1)). Search engines were set up to search the IPI_rat database (v. 3.87, 39925
entries) or Swiss-Prot database (only rattus taxonomy), assuming digestion by trypsin and
allowing for 2 missed cleavages. Fragment ion mass tolerance of 0.20 Da and a parent ion
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tolerance of 20 ppm were used. The iodoacetamide derivative of cysteine was specified as a
fixed modification, while oxidation of methionine was designated a variable modification.
Scaffold software (Scaffold_3_4, Proteome Software Inc.) was used to validate MS/MS
based peptide and protein identifications. The SIM acquisition method for the LTQ-FT was
adopted based on the results of LC-MS/MS experiments to achieve better sensitivity and to
focus on the four selected, PMCA isoform-specific peptides with significant sequence
homology: GIIDSTVSEQR for PMCA1, GIIDSTHTEQR for PMCA2, GIIDSTTGEQR for
PMCA3, GIIDSNIGEQR for PMCA4 (see also Table 1, Supplementary Material). FT SIM
experiments were set to scan the m/z range of 626.30–631.30 from 10.0 to 12.6 min, of
586.30–591.30 from 12.6 to 15.2 min, of 600.32–605.320 from 15.2 to 17.2 min, and of
598.82–603.82 from 17.2 to 20.2 min. FT SIM scans were acquired at a resolution of
100,000 with an AGC target of 2×105 or maximum ion time of 1.2 s. The chromatographic
peaks were integrated using Qual Browser of Xcalibur software. FT SIM peak areas were
used for reporting quantitative stoichiometric ratios of PMCA isoforms in samples thus
analyzed.
Measurement of PMCA activity
The PMCA activity was determined at 37oC by monitoring the generation of Pi from the
hydrolysis of ATP as described previously (Zaidi et al. 1998; Jiang et al. 2007). The assay
was conducted in a final volume of 100 μL containing 3μg sample protein, 25 mM Tris-Cl,
pH 7.4, 50 mM KCl, 1 mM ATP, 1 mM MgCl2, 0.1 mM ouabain, 4 μg/mL oligomycin, 0.1
μM thapsigargin, 200 μM EGTA, and CaCl2 at different concentrations added to yield the
final free Ca2+ concentrations indicated in the figures. The final free Ca2+ concentration was
calculated using the software calcium.com that calculates the multiple equilibria between all
ligands in solution. During their preparation, the synaptic membranes were not exposed to
chelators to extract the endogenous CaM bound to them. Thus the PMCA activity was
measured in the presence of the CaM already associated with the membranes except in the
experiments in which it was noted that a saturating amount of exogenous CaM was added to
the assay. After a 5 min pre-incubation, the reaction was initiated by the addition of ATP,
continued for 30 min at 37°C, and stopped by addition of the Malachite Green dye solution
(Lanzetta et al. 1979). The absorbance was measured immediately at 650 nm. The specific
activity of PMCA was defined as the nmoles of Pi liberated per mg of protein per min.
Statistical Analyses
The statistical significance of differences between samples were determined by Student’s t-
test for unpaired samples or by ANOVA, whichever was more appropriate for the type of
data being analyzed.
Results
Characterization of lipid rafts isolated from rat brain SPMs
Lipid rafts were isolated from SPMs prepared from the individual brains of 6, 23, and 34
mos F344/BNF1 rats using the non-ionic detergent Brij 98 at a final concentration of 1% (v/
v). Only the brains of 6 month-old rats were used in the initial characterization of the rafts
and the partitioning of the PMCA in raft and non-raft domains. After the sucrose density
gradient centrifugation, fractions 2–9 were collected from the top to the bottom of the tube
as noted in the Methods. Cholesterol, one of the major lipid markers of rafts, was
significantly enriched in the low-density fractions, #2–4. The cholesterol content in these
fractions represented 77.4 ± 0.9% of the total cholesterol in the membranes applied to the
gradient (Fig. 1A). Cholesterol was substantially more enriched in fractions #2–4 than
proteins were. These fractions contained 31.6 ± 1.2% of the total protein in the SPMs. An
additional lipid raft marker, GM1 ganglioside, was highly enriched in fractions #2–4, as
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were two raft protein markers, Thy-1 and FLT-1 (Fig. 1B), consistent with our previous
observations (Jiang et al. 2010). Figure 1B also shows the distribution of PMCA in the raft
and non-raft fractions based on an immunoblot analysis with the pan-PMCA antibody.
Densitometric analyses of the total PMCA immunoreactivity in fractions #2 to #9 indicated
that a greater percentage of the total amount of PMCA was associated with the detergent-
resistant, low density fractions #2–4 than with fractions #5–6 or #7–9 (data not shown).
To quantify the levels of total PMCA and of each of the four isoforms of the enzyme in the
three pooled fractions, we performed quantitative MS analyses of these fractions as
described under Methods. Liquid chromatography-MS/MS analysis of the in-gel digested
samples followed by database searches identified the presence of all four PMCA isoforms,
as well as that of many other proteins, in the gel slices excised from the region
corresponding to the molecular sizes of the PMCA isoforms. Sequence coverage for each
PMCA isoform was in the range of 15–20% and a total number of 45 peptides were assigned
to PMCA isoforms with greater than 50% probability as specified by the Peptide Prophet
algorithm (Keller et al. 2002). There were 8, 12, 5, and 12 isoform-specific peptides
(including the ones with probability less than 50%) detected by MS/MS and assigned to
PMCA isoforms 1, 2, 3, and 4, respectively (Tables 2–5 Supplementary Material). PMCA
isoform sequence alignment (Scheme 1, Supplementary Material) indicated a region of
similarity within four isoform-specific peptides (Table 1, Supplementary Material). These
peptides have 8 out of 11 residues in common across the four isoforms and were selected for
further quantitative FT SIM MS experiments. The analysis of pooled samples from fractions
#2–4, #5–6, and #7–9, using FT SIM MS allowed us to increase sensitivity for the PMCA
representative peptides relative to full scan FT MS experiments. Stoichiometric ratios of
PMCA isoforms were calculated by normalizing the FT SIM isoform-specific peptide signal
to the sum of signals from the four selected peptides. This was achieved by focusing the
mass spectrometer on a particular ion during the expected time.
The results of such analyses were averaged and are presented in figure 2 and Table 1. The
data obtained indicated that ~60% of the total PMCA partitioned into the pooled raft
fractions #2–4, and ~21% and ~19% partitioned into pooled fractions #5–6 and #7–9,
respectively (Fig. 2A). The content of PMCA proteins in raft fractions (~60%) was nearly
twice that of the total membrane protein distributed in those fractions (~31%, see Fig. 1A),
an indication of selective association of PMCA with rafts. Quantitative MS analyses also
revealed that of the four PMCA isoforms, PMCA 1, 2, and 4 were the most abundant
isoforms in all of the fractions as determined by quantitative MS (Fig. 2B). The
stoichiometric ratios of the four isoforms in each of the three pooled fractions are shown in
Table 1.
As the final step in characterizing the raft and non-raft fractions, we determined the Kact and
Vmax values of the basal PMCA activity across Ca2+ concentrations in each of the 3 pooled
fractions isolated from SPMs of 6 mos old rats. These studies were performed in the absence
of exogenous CaM additions. We found that the specific activity of the enzyme was
significantly higher in the raft fractions than in either of the pooled non-raft fractions (Fig.
3). The estimated Vmax in the rafts was ~2.6-fold (p<0.001, Student t-test) and ~4.6-fold
(p<0.001) higher than the Vmax values in fractions #5–6 and #7–9, respectively (Table 2).
The calculated values for the estimated Kact for Ca2+ for fractions #2–4 did not differ
significantly from those for fractions #5–6 (p=0.35) and #7–9 (p=0.52). The Kact values for
all fractions were similar to those observed previously for isolated SPMs (Zaidi et al. 1998)
and were indicative of a high affinity state of PMCA for free Ca2+.
The high affinity for Ca2+ in these preparations might be indicative of substantial amounts
of CaM remaining bound to the three pooled fractions isolated from synaptic membranes.
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The present measurements were obtained using preparations that were not treated with
chelators, such as EDTA, to extract endogenous CaM; thus the Vmax and Kact estimates
probably reflected those of PMCA activated by any CaM remaining in association with the
isolated fractions. The addition of exogenous CaM (300 nM) had no significant effect
(p>0.10, t-test comparisons) on either the estimated Vmax or the Kact for Ca2+-induced
activation of PMCA (Table 2). The lack of an effect by excess exogenous CaM on PMCA
activity would be expected if substantial amounts of CaM remained bound to these fractions.
To assess the contribution of endogenous CaM to the activity of PMCA measured in the raft
fractions, we pursued two approaches. The first was to pretreat the rafts with either of two
CaM inhibitors, calmidazolium (10 μM) or trifluoperazine (50 μM). The second was to treat
synaptosomes and SPMs with EDTA prior to isolation of the raft and non-raft fractions in
order to extract CaM that might be tightly bound to components of the isolated fractions.
Both types of treatments caused a reduction in PMCA activity in rafts of approximately 30–
40%. This is demonstrated in figure 4A for the effect of calmidazolium on the PMCA
activity of the pooled fractions #2–4. Calmidazolium caused a significant decrease (p=0.005,
t-test) in the Vmax of PMCA activity in the raft fractions and a 2.7-fold, but not significant
(p=0.098), increase in the Kact for Ca2+ (Fig. 4A). The effects of calmidazolium on both
Vmax and Kact were completely reversed by the addition of 300 nM CaM (Fig. 4A). The
effects of inhibitors of CaM on the PMCA activity in the raft fractions were indicative of the
presence of endogenous CaM remaining associated with these preparations. When 3 mM
EDTA was introduced during the lysis of synaptosomes and the isolation of synaptic
membranes, it led to the extraction of ~48% of the CaM that was associated with the raft
fractions but did not completely remove all CaM from those fractions (Fig. 4B). Because of
the residual CaM in these fractions even following Ca2+ chelation, the precise level of
contribution of CaM to the overall PMCA activity in rafts could not be accurately estimated,
but it was obviously significant.
Effects of aging on PMCA protein levels and PMCAactivity in raft microdomains
Analysis of the levels of GM1 in SPM rafts from rats at 6, 23, and 34 mos revealed no
significant age-related changes in this marker of raft domains in membranes. The total
protein in the three pooled fractions as well as the levels of the protein raft markers, Thy-1
and FLT-1, also did not change with increasing brain age (data not shown). On the other
hand, there was a small but statistically significant and progressive increase in the
cholesterol to protein ratio in the rafts from the 23 mos and the 34 mos compared to the 6
mos old animals as shown in Fig. 5A.
The levels of the PMCA protein in rafts (fractions #2–4) were compared at the three ages in
order to determine if there was any significant change in PMCA in rafts. To address the
possibility that changes in raft PMCA levels during the aging process might result from
altered distribution of PMCA in membranes, i.e., decreases in PMCA associated with the
rafts and increases in PMCA in the non-raft domains, we also examined the effects of the
aging process on the levels of PMCA in fractions #5–6 and #7–9. As shown in figure 5B, we
observed a significant age effect on PMCA levels in rafts (p=0.03, ANOVA) and significant
decreases for both the 23 and 34 mos raft fractions compared with the levels at 6 mos
(p<0.03, t-test).
The same as described above for 6 mos old rats analyzed by quantitative MS and
immunoblots (e.g., Fig. 2), the overall levels of PMCA in rafts isolated from 6 and 23 mos
old rat brains were significantly higher (p<0.01, t-test) than those in fractions #5–6 and #7–9
(Fig. 5B). It should be noted that there was no significant age effect on the PMCA levels in
the non-raft fractions. Therefore, it was unlikely that the decreases in PMCA levels in rafts
were the result of re-distribution of the protein from the raft to the non-raft domain during
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the aging process. Because of the lack of a change in PMCA levels in fractions #5–6 and
#7–9, the focus of studies related to PMCA activity was primarily on the effects of aging on
the raft fractions.
When the activity of PMCA was determined across Ca2+ concentrations in rafts isolated
from SPMs of rats at 6, 23, and 34 mos of age, the estimated Vmax decreased progressively
and significantly with increasing age of the rats (Fig. 6). The Vmax at 23 mos was 23% lower
than that at 6 mos (p=0.014, t-test), and the Vmax at 34 mos was 39% below that at 6 mos
(p=0.012, t-test), with no significant (p>0.50) changes in the Kact for Ca2+ (Table 3). The
reductions in the Vmax values for activity were considerably greater than the reductions in
the levels of the PMCA protein associated with the rafts at the three different ages. These
data are quite similar to those we obtained previously with aging SPMs that were not
fractionated into rafts and non-rafts (Zaidi et al. 1998).
The PMCA activity shown in figure 6 was determined without the addition of exogenous
CaM. As indicated previously, the rafts contain tightly bound CaM; therefore it seemed
possible that a partial loss of CaM from the aged rafts could lead to the lower Vmax of the
PMCA activity we observed in those rafts. To address this issue, we used immunoblots and
densitometric analyses to determine the relative levels of CaM present in the rafts obtained
from rats at the 3 ages. The amount of CaM present in the raft fractions showed no
significant age-related decrease. The densitometric units for CaM in rafts isolated from the
brains of 6 mos-old rats were 3.4 (± 0.17) ×107, that for rafts from 23 mo-old was 3.0 (±
0.05) ×107, and those from 34 mo-old 3.1 (± 0.15) ×107.
To determine if the addition of exogenous CaM could overcome the age-dependent decrease
in PMCA activity in rafts, we measured the PMCA activity of rafts following the addition of
exogenous CaM (300 nM) to preparations from brains of rats 6, 23, and 34 mos old. The
Vmax values for the raft PMCA are shown in Table 3. The magnitude of the reductions in the
Vmax values in the aging rafts was not reversed by the CaM addition. Thus the age-
dependent decrease in PMCA activity in the rafts did not appear to be due to inadequate
levels of CaM, an observation consistent with our results from SPMs (Zaidi et al., 1998).
The presence of CaM in the enzyme assays also brought about modest but non-significant
(p=0.10, t-test) decreases in the Kact for Ca2+ (Table 3).
Discussion
The hypothesis that Ca2+ dysregulation is a fundamental contributor to the progressive
decline in cognitive function with age is supported by numerous studies demonstrating
changes in several protein systems responsible for neuronal Ca2+ signaling as reviewed
recently (Kumar et al. 2009). Clearly our observations on the effects of aging on the PMCA
system represent only one component of a very complex process, but the marked reduction
in the activity of this critical regulator of free intracellular Ca2+ concentrations in the
synaptic region is likely to be quite significant for overall cognitive performance. The
importance of PMCA in regulating Ca2+ levels at the synapse is surmised from the
demonstration in previous studies of the localization of PMCA isoforms and of specific
splice variants of these isoforms in the plasma membrane of dendrites (Marcos et al. 2009;
Kenyon et al. 2010) and, importantly, at the subsynaptic web of neuronal synapses (Burette
et al. 2010). Furthermore, activation of synaptic Ca2+ entry into neurons through glutamate
receptors leads to long-term effects on PMCA activity that differ markedly from those
induced by general depolarization of neurons (Ferragamo et al. 2009). The studies presented
here provide a more detailed picture of the properties of the PMCA in synaptic membranes
and support the assertion that the protein does exist in both raft and non-raft domains, that
approximately 60% of synaptic membrane PMCA protein is within raft domains, which is
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nearly twice the amount of the estimated total synaptic membrane protein distributed in
rafts, and, moreover, that the most active pool of PMCA is that present in the rafts. The
V max for Ca2+-activated PMCA in rafts was 2.6 and 4.6 times the values in non-raft
fractions #5–6 and #7–9 respectively in the young rat brains. The reasons for the high levels
of PMCA that is associated with the raft domains in synaptic membranes, and for the even
higher activity of the enzyme than could be accounted by the differential distribution of the
protein, are not known.
It seems quite likely that the higher specific activity in the rafts is due to the more highly
ordered lipid environment in which the protein is embedded. The high cholesterol content
and the sphingolipids with saturated acyl chains create a lipid domain that is more ordered
than that found in the phospholipid bilayers with unsaturated acyl chains. This higher degree
of order has been reported to enhance significantly the PMCA activity of the human ocular
lens (Tang et al. 2006) and the red blood cell PMCA reconstituted in lipid vesicles (Zhang et
al., 2005). These authors speculate that the enhanced activity is due to the lipid stabilization
of the active conformation of the enzyme formed during the catalytic cycle. The sub-
plasmalemmal actin filaments that promote lipid-lipid, lipid-protein, and protein-protein
interactions within the rafts (Simons and Gerl, 2010) may also contribute to the markedly
higher PMCA in these micro-domains.
The present studies, for the first time, have precisely quantified total PMCA as well as the
PMCA isoform distribution in raft and non-raft domains of SPMs. Previous studies reported
that raft domains in SPMs isolated from pig cerebellum contained only a single isoform of
PMCA, the PMCA4 isoform (Sepulveda et al. 2006). This conclusion was based on the
relative immunoreactivities of SPM subfractions with PMCA antibodies. The same
technique was also used to demonstrate the presence of PMCA4 in raft domains in intestinal
smooth muscle (El-Yazbi et al. 2008). However, in MDCK kidney cells, the localization of
PMCA2 in apical membranes has been traced to the association of the PMCA2 isoform with
lipid raft domains (Xiong et al. 2009). In our studies with rafts isolated from whole rat
brains, we unequivocally identified all four isoforms of PMCA in raft domains, as well as in
non-raft domains, using both LC-MS/MS as well as immunoblot methodologies.
Furthermore, using quantitative MS techniques we were able to estimate the stoichiometric
ratios for the four isoforms and to demonstrate that the most abundant forms of PMCA were
PMCA4, PMCA2, and PMCA1, with PMCA3 lagging behind the other isoforms in terms of
overall levels in rafts and non-raft domains. Therefore, there was no apparent exclusivity for
PMCA4 localization in raft domains.
An interesting observation made in the present studies was the tight binding of endogenous
CaM to the rafts isolated following treatment of SPMs with the Brij98 detergent and
subsequent subfractionation on sucrose density gradients. Whereas treatment of
synaptosomes and SPMs with 3 mM EDTA did bring about a decrease in raft-associated
CaM and a decrease in PMCA activity, it did not deplete completely the raft-bound CaM.
The interaction of raft-bound CaM with the PMCA in these lipid domains was confirmed by
the fact that high concentrations of either calmidazolium or trifluoperazine partially
inhibited the activity of PMCA and that such inhibition could be completely overcome by
the addition of excess exogenous CaM. The residual activity of PMCA in the presence of
inhibitors may be the result of remaining high affinity interactions between CaM and PMCA
or of the relative abundance of PMCA2 in rafts, an isoform which is minimally affected by
the presence of CaM (Brini and Carafoli 2009).
When we assessed the effects of aging on the PMCA activity in the raft fractions, we
observed a statistically significant reduction in the Vmax values of the activity in the rafts at
both 23 and 34 months, a reduction in activity that was in excess of the age-associated
Jiang et al. Page 9










decreases in the levels of the PMCA protein in the rafts. The Kact for Ca2+ did not change
with age. Furthermore, the amount of CaM associated with the rafts at the 3 ages showed no
significant changes, and the addition of exogenous CaM did not reverse the reduction in
activity in the rafts at 34 mos. As lipid raft microdomains are considered to be sites within
which receptors and transport carriers are assembled to form important platforms for
membrane signaling and molecular trafficking (Lingwood and Simons 2010), the age-
associated decreases in SPM raft-associated PMCA levels and activity may strongly
influence neuronal handling of Ca2+ transients.
In addition to the significant reduction in the Vmax values of the PMCA activity, we did
observe a relatively small but statistically significant increase in the cholesterol to protein
ratio in the rafts. This progressive increase from 6 mos to 23 mos, and to 34 mos represents
an alteration that would be expected to increase the order within the lipid environment.
Cholesterol is present in both leaflets of the membrane bilayer, with 85% distributed into the
cytofacial leaflet (Wood et al. 2011). It fills the space under the head groups of sphingolipids
or extends the interdigitating fatty acyl chain in the apposing leaflet (Simons and Ikonen
1997). Biochemical and cell-biological experiments have identified cholesterol as an
important component of lipid rafts for stability and organization based on the interaction of
cholesterol with different membrane lipids (Silvius 2003). If the brain neurons do increase
the cholesterol in the aging rafts, it is conceivable that the cells are attempting to make some
compensatory response that might increase order and keep the PMCA more active as other
age-related processes lead to a significant loss of enzyme activity.
As mentioned in the Introduction, several different mechanisms may contribute to the
reduction in PMCA activity without a comparable reduction in levels of the protein. Given
our observations that PMCA is uniquely sensitive to inactivation under conditions of
oxidative stress (Zaidi and Michaelis 1999), it is quite possible that the protein per se could
be oxidatively modified and thereby operate much less efficiently. Subtle alterations in the
lipid milieu, oxidation of some of the lipids, disruption of interactions between PMCA and
some of its numerous protein binding partners (DeMarco and Strehler 2001; Sgambato-
Faure et al. 2006), or the state of phosphorylation of specific isoforms such as the tyrosine
phosphorylation of PMCA4 (Ghosh et al. 2011) could also influence the enzymatic activity
with increasing age. Detailed analyses of possible oxidative modifications of the PMCA and
its binding partners in synaptic membranes and of the presence and activity of tyrosine
kinases in these membrane fractions are currently underway as we attempt to determine why
the contribution of this critical transporter is compromised in the aging brain.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Characterization of raft and non-raft domains isolated from SPMs of 6-mos F344/BNF1 rat
brains. (A) Analysis of cholesterol and protein content of the 10 fractions collected from the
sucrose density gradient as described under Methods. Data are means ± SEM obtained from
6 animals. (B) Cholera toxin and immunoblot detection of raft markers and PMCA. Eight μg
of protein from fractions 2–9 were loaded on the gel for GM1, FLT-1, and pan PMCA
detection, and 15 μg of protein for Thy-1 detection. The GM1 was detected with cholera
toxin as described in the Methods. The dilutions for the various antibodies were: FLT-1
(1:250), Thy-1 (1:250), and pan PMCA (1:1000). Representative blots from 3 independent
experiments with similar results are shown.
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Distribution of the total PMCA protein and the PMCA isoforms in the raft and non-raft
fractions from rats at 6 mos as determined by quantitative mass spectrometry described
under Methods. (A) The total FT SIM intensity counts based on LC-MS/MS analysis of the
4 isoforms in each of the pooled fractions (#2–4, #5–6, #7–9), were added and the
percentage of the total membrane PMCA present in each of the fractions calculated. (B)
Quantitative FT SIM mass spectrometric measurements of PMCA isoform-specific peptides
present in each of the 3 fractions are shown. Data are presented as the means ± SEM of
triplicate determinations from 2 preparations.
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Measurement of the specific activity of PMCA in the raft and non- raft fractions. Fractions
#2–4, #5–6, and #7–9 were pooled, and 3 μg of protein from each was assayed for PMCA
activity across Ca2+ concentrations as described under Methods. The activities were
determined in the absence of exogenous CaM. Each point is the mean ± SEM of triplicate
determinations of the specific activity in nmol Pi/mg protein/min for the raft and non-raft
fractions obtained from the SPMs isolated from 5 animals at 6 mos of age. Curves were
plotted with least squares fitting of the data to the Michaelis-Menten equation using Sigma
Plot 11. The Vmax and Kact values determined in the presence and absence of saturating
levels of exogenous CaM are listed in Table 2.
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Effects of the CaM inhibitor Calmidazolium and EDTA extraction of CaM on the specific
activity of PMCA in raft and non-raft fractions. (A) Raft and non-raft fractions were pre-
incubated and assayed with 1% DMSO only (final concentration), 10 μmM Calmidazolium
in DMSO, or 10μM Calmidazolium in DMSO + 300 nM CaM, and the specific activity was
measured across Ca2+ concentrations. The Vmax and Kact values calculated from 4
membrane preparations are shown in the figure. Statistical analysis of Vmax and Kact values
for the Calmidazolium vs Calmidazolium + CaM yielded p < 0.005 and p < 0.12
respectively. (B) CaM remaining in rafts after extraction with 3 mM EDTA. Synaptosomes
were exposed to 3 mM EDTA during lysis as described in the Methods and 15 μg of protein
from Fr #2–4 were run on SDS-PAGE, transferred, and probed with antibodies to CaM. The
immunoblot shown is representative of 6 similar blots.
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Effects of aging on cholesterol to protein ratios and on PMCA levels in rafts and non-raft
fractions. (A) Rafts (fractions #2–4) were collected from animals at 6, 23, and 34 mos. The
total cholesterol was determined with Amplex Red and the bicinchoninic assay was used to
determine the total protein in each sample. The cholesterol to protein ratio for the rafts at 6
mos was set to 1.0, and the ratios for the 23 and 34 mos samples calculated relative to the 6
mos value. Data represent the means ± SEM of the ratios from 5 sets of animals, and the
significance of differences between samples were assessed by Student’s t test. * = p< 0.02.
(B) Immunoblot analysis of PMCA levels was carried out with the pan PMCA antibody on
pooled fractions #2–4, #5–6, and #7–9, prepared from the SPMs of 6, 23, and 34 mos
F344BNF1 rat brains. (C) Relative immunoreactivities with the pan PMCA antibody were
quantified in the fractions from 5 sets of animals, and the means ± SEM are shown. One-
way Anova analysis revealed a statistically significant age effect (p<0.03) on PMCA levels
in the raft fraction (#2–4) though the levels of the protein are higher than in the non – raft
fractions. PMCA levels in the 2 non-raft fractions showed no significant change with age.
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Effects of aging on the specific activity of PMCA in the raft fractions (#2–4) assayed
without the addition of exogenous CaM. Each point is the mean ± SEM of triplicate
determinations of the specific activity in nmol Pi/mg protein/min for the raft fractions
obtained from the SPMs isolated from 4 sets of animals at 6, 23, and 34 mos of age. Curves
were plotted with least squares fitting of the data to the Michaelis-Menten equation using
Sigma Plot 11. The Vmax and Kact values determined in the presence and absence of
saturating levels of exogenous CaM are listed in Table 3.
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Table 1
Stoichiometric ratios of PMCA isoforms in pooled fractions #2–4, 5–6, and 7–9a.
Pooled Fractionsb PMCA1c PMCA2c PMCA3c PMCA4c
2 – 4 0.251±0.013 0.289±0.038 0.119±0.015 0.341±0.031
5 – 6 0.269±0.021 0.278±0.020 0.134±0.014 0.319±0.016
7 – 9 0.282±0.012 0.368±0.019 0.119±0.012 0.231±0.015
a
Stoichiometric ratios of PMCA isoforms were calculated by normalizing the chromatographic areas measured by FT SIM MS to the sum of the
areas for the four isoform-specific peptides.
b
Pooled fractions were isolated by Brij98 treatment of SPMS followed by sucrose density centrifugation. Peptides from these fractions were
obtained following protein digestion of proteins separated by SDS gel electrophoresis as described under Methods.
c
Values represent the mean ± SD of 6 sample determinations.
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Table 2
Summary of constants Vmax and Kact of PMCA activity in raft and non-raft fractions of SPMs isolated from 6
mos old rat brain and measured in the presence or absence of exogenous CaM.
Pooled Fractionsa
Vmax (nmol Pi mg−1 protein min−1)b Kact (μM)
No CaM Plus CaMc No CaM Plus CaMc
2 – 4 16.7 ± 0.8 16.8 ± 0.7 0.023 ± 0.004 0.011 ± 0.006
5 – 6 7.4 ± 1.2 7.7 ± 1.4 0.088 ± 0.059 0.065 ± 0.037
7 – 9 4.1 ± 0.5 3.9 ± 0.1 0.049 ± 0.042 0.046 ± 0.040
a
PMCA activity was measured in pooled fractions isolated by Brij98 treatment of SPMS followed by sucrose density centrifugation.
b
Values represent the mean ± SEM of constants obtained from the analyses of Michaelis-Menten fitting of the data from 5 rats per group (all
measurements performed in triplicate).
c
The concentration of CaM added was 300 nM.
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Table 3
Summary of constants Vmax and Kact of PMCA activity in raft domains isolated from SPMs from 6, 23, and
34 mos old rats and measured in the presence or absence of exogenous CaM.
Age (Months)
Vmaxa (nmol Pi mg−1 protein min−1)b Kacta (μM)
No CaM Plus CaMc No CaM Plus CaMc
6 17.5 ± 0.6 16.5 ± 0.8 0.033 ± 0.005 0.015 ± 0.007
23 13.4 ± 1.1 13.5 ± 0.5 0.026 ± 0.008 0.0078 ± 0.01
34 10.7 ± 1.8 10.8 ± 1.1 0.037 ± 0.01 0.011 ± 0.004
a
PMCA activity measured as described in Table 2.
b
Values represent the mean ± SEM of constants obtained from the analyses of Michaelis-Menten fitting of the data from 4 rats per group (all
measurements performed in triplicate).
c
The concentration of CaM added was 300 nM.
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